12-13777923-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000834.5(GRIN2B):​c.412-24008A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.584 in 152,054 control chromosomes in the GnomAD database, including 26,767 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.58 ( 26767 hom., cov: 32)

Consequence

GRIN2B
NM_000834.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -4.26

Publications

23 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.967 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIN2BNM_000834.5 linkc.412-24008A>G intron_variant Intron 3 of 13 ENST00000609686.4 NP_000825.2 Q13224A0A8D9PHB2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIN2BENST00000609686.4 linkc.412-24008A>G intron_variant Intron 3 of 13 1 NM_000834.5 ENSP00000477455.1 Q13224
GRIN2BENST00000630791.3 linkc.412-24008A>G intron_variant Intron 4 of 14 5 ENSP00000486677.3 A0A0D9SFK0
GRIN2BENST00000714048.1 linkn.412-24008A>G intron_variant Intron 3 of 12 ENSP00000519339.1

Frequencies

GnomAD3 genomes
AF:
0.584
AC:
88732
AN:
151936
Hom.:
26744
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.476
Gnomad AMI
AF:
0.446
Gnomad AMR
AF:
0.677
Gnomad ASJ
AF:
0.592
Gnomad EAS
AF:
0.990
Gnomad SAS
AF:
0.794
Gnomad FIN
AF:
0.657
Gnomad MID
AF:
0.623
Gnomad NFE
AF:
0.573
Gnomad OTH
AF:
0.559
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.584
AC:
88798
AN:
152054
Hom.:
26767
Cov.:
32
AF XY:
0.595
AC XY:
44260
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.476
AC:
19743
AN:
41442
American (AMR)
AF:
0.678
AC:
10363
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.592
AC:
2055
AN:
3470
East Asian (EAS)
AF:
0.990
AC:
5127
AN:
5180
South Asian (SAS)
AF:
0.792
AC:
3812
AN:
4816
European-Finnish (FIN)
AF:
0.657
AC:
6937
AN:
10566
Middle Eastern (MID)
AF:
0.622
AC:
183
AN:
294
European-Non Finnish (NFE)
AF:
0.573
AC:
38977
AN:
67966
Other (OTH)
AF:
0.565
AC:
1194
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1853
3706
5560
7413
9266
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
746
1492
2238
2984
3730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.576
Hom.:
50365
Bravo
AF:
0.579
Asia WGS
AF:
0.854
AC:
2967
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.041
DANN
Benign
0.74
PhyloP100
-4.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10845840; hg19: chr12-13930857; API